Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ProPhase Labs's Enterprise Value is $101.64 Mil.
ProPhase Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.53 Mil. Therefore, ProPhase Labs's EV-to-EBIT ratio for today is -4.72.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, ProPhase Labs's Enterprise Value is $101.64 Mil.
ProPhase Labs's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-14.83 Mil. Therefore, ProPhase Labs's EV-to-EBITDA ratio for today is -6.85.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, ProPhase Labs's Enterprise Value is $101.64 Mil.
ProPhase Labs's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $44.38 Mil. Therefore, ProPhase Labs's EV-to-Revenue ratio for today is 2.29.
ProPhase Labs Enterprise Value Historical Data
The historical data trend for ProPhase Labs's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ProPhase Labs's Enterprise Value
For the Diagnostics & Research subindustry, ProPhase Labs's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ProPhase Labs's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, ProPhase Labs's Enterprise Value distribution charts can be found below:
* The bar in red indicates where ProPhase Labs's Enterprise Value falls into.
ProPhase Labs Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
ProPhase Labs's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ProPhase Labs (NAS:PRPH) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
ProPhase Labs's current Enterprise Value is $101.64 Mil.
ProPhase Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-21.53 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
ProPhase Labs's current Enterprise Value is $101.64 Mil.
ProPhase Labs's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.83 Mil.
ProPhase Labs's current Enterprise Value is $101.64 Mil.
ProPhase Labs's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $44.38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ProPhase Labs Enterprise Value Related Terms
Thank you for viewing the detailed overview of ProPhase Labs's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
ProPhase Labs (ProPhase Labs) Business Description
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRPH has been successfully added to your 